Market Signal Briefing

Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

Following a 3.57% daily rise, Solana price has regained upward traction amid renewed institutional interest and steady technical resilience. The asset continues to hold firm near its ascending support structure, reflecting sustained demand despite broader market fluctuations. Meanwhile, Solana Company’s recent purchase has reinforced growing investor confidence in the project’s long-term value proposition.

Solana Price Action Suggests a Strong Breakout Structure Forming Toward $300
The current Solana market price trades at $236.46, with buyers showing renewed confidence after holding above key support zones. The daily chart indicates an ascending trendline that has provided consistent structure since mid-year, offering a solid foundation for further advances. 

Immediate resistance lies around $238, a crucial zone that could open the way for a test of $251 once breached. If Solana price sustains movement beyond this level, the next technical target sits near $300, aligning with a potential 56% rebound projection.

Notably, the Fibonacci extension highlights key retracement levels where consolidation could occur before continuation. The 0.618 level around $238 remains pivotal, while the 0.786 level near $252 could attract renewed buy-side volume. 

Conversely, failure to hold above $227 may trigger a retest of lower support at $209, though the broader ascending trendline continues to provide strong structural backing. 

SOL/USDT 1-Day Chart (Source: TradingView)
As recently highlighted by CoinGape, the consistent formation of higher lows underlines an active accumulation phase, positioning Solana for a potential breakout if buyers maintain pressure above short-term resistance. 

The report also noted that breaching the $251 resistance could open a path toward the projected $360 target, aligning with a broader long-term Solana price prediction that envisions sustained growth from its current structure.

Solana Company’s $530M Acquisition Reinforces Institutional Backing
The announcement that Solana Company added $530 million worth of SOL to its treasury has strengthened optimism about institutional demand. The Nasdaq-listed firm’s allocation represents one of the largest corporate Solana purchases to date. It also signals increasing trust in the network’s efficiency and scalability among large investors.

Such institutional involvement tightens supply and supports the Solana price by reducing selling pressure. This move fits into a wider trend of corporate diversification into blockchain assets, especially those offering speed and cost advantages.

Meanwhile, Grayscale’s Solana Trust (GSOL) has also enabled staking, a move that could further strengthen institutional engagement once its regulatory uplisting to an ETP is approved.

To sum up, Solana price continues to demonstrate strength, supported by solid technicals and rising institutional exposure. The ascending support remains a key level to monitor, defining near-term market structure. A close above $251 would likely confirm continuation and open the path toward $300 and beyond. With Solana Company’s $530M buy and fresh staking exposure through Grayscale, the market outlook for Solana remains firmly bullish.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Bitcoin’s dramatic weekend spike to a fresh all-time high of $125,700 lacked real spot demand and was largely the product of leveraged speculation in thin conditions, according to crypto analyst Maartun, who characterized the move as a classic fakeout rather than a durable breakout. “Bitcoin prints a brand new all-time high, $125,700… But hold on a second. The price almost immediately reversed,” he said, framing the question that followed: “Was that move for real?”

The Truth Behind Bitcoin’s Weekend Surge
Maartun argues the answer sits in the futures market. Open interest—capital tied up in outstanding derivatives positions—“didn’t just go up, it absolutely exploded,” rising by more than $2.1 billion during the rally. In his telling, that surge came “over a weekend, which is a time when there are way fewer buyers and sellers around,” amplifying the impact of leveraged positioning in a low-liquidity window. “This whole move was driven by futures, by bets,” he said, adding that the jump in open interest, roughly 5%, turned the market into “a house of cards ready to fall over at the slightest touch.”

Equally important, Maartun says, is what did not happen: an influx of committed spot buyers to underpin the advance. Earlier in the week, he notes, Coinbase showed aggressive spot demand, trading about $110 above other venues—evidence of “real buyers… snapping up Bitcoin.” During the weekend push, that premium vanished. “The gamblers were placing their bets,” Maartun said, “but the investors, the people actually buying Bitcoin, they were sitting this one out.”

With those two “clues”—a derivatives-led surge and the absence of spot confirmation—Maartun’s verdict is unambiguous. “You can call it a fake out, you can call it a swing failure pattern, or you can even call it the head of a head and shoulders pattern… It was a trap. A move that was designed to look like the real deal, but had absolutely no substance behind it.” After the brief print at $125,700, price swiftly retraced “right back down to where the whole move started,” he added.

From here, Maartun identifies a single inflection point: $123,000. “This is the level… that is going to tell us whether the bulls or the bears take control from here,” he said. On confirmation criteria, he is explicit: “What we need to see is a strong, confident close above that $123K mark. That would signal acceptance… and a true breakout is probably coming.”

Failure to reclaim and hold that area, in his view, likely hands momentum back to sellers with an initial drawdown target around $117,500. He also cautions against expecting a repeat head-fake at the same level: “Fakeouts don’t usually happen twice in a row. The second attempt to break a level like this is very often the real deal one way or the other.”

The broader context to Maartun’s assessment is the unusual timing and texture of the move. Weekends in crypto “are normally kind of sleepy,” he said, yet this one delivered “the best weekend performance we’ve seen in four whole months”—a signal, in his analysis, not of rekindled spot enthusiasm but of how quickly leverage can dominate price in quiet order books. Without renewed spot leadership—such as a return of the Coinbase premium or other evidence of net spot accumulation—he sees the market “on a knife’s edge” at the $123,000 line in the sand: “Break out or pull back?”

At press time, Bitcoin held above $124,216.

BTC remains above $124,000, 1-day chart | Source: BTCUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

XRP price prediction has assessed XRP reclaiming $3 with resistance at $3.17–$3.36 and possible targets near $3.60–$4.00 if momentum holds. Traders have weighed CME's 24/7 crypto plan and upcoming ETF deadlines while monitoring support around $2.94 and an RSI near overbought.

Bee Maps, a decentralized mapping platform built on the Hivemapper network, has raised $32 million in fresh funding to accelerate its global expansion and strengthen its AI-driven mapping infrastructure. The investment round was led by Pantera Capital, LDA Capital, Borderless Capital, and Ajna Capital, marking one of the largest financings in the decentralized physical infrastructure (DePin) sector in 2025.

Bee Maps leverages Hivemapper’s AI-powered dash cams to crowdsource real-time road data. Drivers equipped with these devices contribute street-level imagery and updates such as new road signs, construction zones, and detours. In return, contributors are rewarded with Bee Maps’ native token, $HONEY, making it one of the fastest-growing decentralized data ecosystems on Solana. This model ensures constantly updated maps without relying on centralized entities like Google Maps or Apple Maps.

The new funding will be used to deploy more devices, enhance AI models, and boost contributor incentives. Co-founder Ariel Seidman emphasized that demand is high and the main challenge lies in scaling supply. To attract more participants, Bee Maps is introducing a Bee Membership plan that lowers the entry barrier—reducing upfront costs from nearly $600 to just $19 per month. The plan bundles hardware, software, and contributor benefits, making it easier for new users to join and earn rewards.

Bee Maps’ recent collaborations with Lyft and Volkswagen’s robotaxi program highlight growing industry confidence in decentralized mapping solutions. As Bee Maps expands, it aims to redefine how mapping data is collected, maintained, and monetized, proving that AI and blockchain can transform real-world infrastructure through community-driven innovation.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Meme-inspired cryptocurrency PEPE has seen a strong rally, climbing more than 2.5% in the past 24 hours, outperforming both the CoinDesk Memecoin Index (CDMEME), which rose 2.24%, and the broader CoinDesk 20 (CD20) index, up 1.8% in the same period.

According to CoinDesk Research’s technical analysis model, PEPE’s price jumped from $0.00000969 to $0.00001027, with over 314 billion tokens traded during a late surge in trading activity. Analysts observed significant trading within the $0.00001000 to $0.00001003 range, establishing a short-term support level, while resistance formed near $0.00001007. This pattern suggests accumulation, a sign that investors are building long-term positions rather than taking quick profits.

The rally is also being fueled by whale accumulation. Data from Nansen shows that the top 100 PEPE holders on Ethereum increased their holdings by 4.28% over the past 30 days, while exchange balances dropped 2.15%, indicating large investors are moving tokens off exchanges for long-term storage.

Meanwhile, open interest in PEPE futures has surged, reaching nearly $645 million, according to CoinGlass. This growing derivatives activity signals heightened trader confidence and increased speculative interest in the token’s price action.

The combination of whale buying, rising open interest, and strong price momentum suggests PEPE’s bullish trend could continue in the near term. As investor sentiment strengthens around meme coins, PEPE’s performance positions it as one of the most closely watched assets in the memecoin sector—potentially setting the stage for further upside if accumulation persists.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Hedera Hashgraph’s native token, HBAR, showcased strong bullish momentum between October 5 and 6, climbing from $0.22 to $0.23 within a 24-hour period. The cryptocurrency’s intraday volatility reached 5.47%, highlighting heightened trading activity and renewed investor interest. After rebounding from lows near $0.21, HBAR managed to post higher highs above $0.23, marking a notable shift in sentiment as buying pressure intensified.

This rally came amid broader market uncertainty fueled by fears of a potential U.S. government shutdown, which spurred increased demand for alternative assets like cryptocurrencies. HBAR’s trading volume surged to 55 million, significantly above its 39.85 million daily average, reflecting strong market participation and short-term optimism. The token’s ability to hold gains despite traditional market pullbacks underscores investor confidence in its near-term outlook.

Technical indicators point toward sustained strength. HBAR established solid support at $0.21, confirmed by substantial trading volume. The token successfully broke through multiple resistance levels—first at $0.22, then $0.23—during periods of high-volume trading exceeding 43 million. Notably, a sharp breakout around 13:37 triggered a 2.87 million volume spike, pushing the price through successive resistance zones and reaching its session high of $0.23.

Despite a lighter final-hour volume of 5.56 million, HBAR maintained consolidation around its peak, signaling stability after a strong upward move. With increasing investor participation, favorable technical momentum, and rising interest in digital assets during macroeconomic uncertainty, HBAR’s bullish trajectory appears poised to extend further, provided it sustains support above the $0.21–$0.22 range.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Stellar Lumens (XLM) surged 3% within a 23-hour period ending October 6, climbing from $0.40 to $0.41 amid a significant spike in institutional activity exceeding 71 million tokens. The price rebound from $0.39 marks a technical recovery, with traders capitalizing on strong demand during peak trading hours to push the token through key resistance levels.

XLM’s ability to maintain levels above $0.41 — a former resistance zone — highlights growing institutional confidence in Stellar’s long-term role as a foundational blockchain for financial infrastructure. Analysts point to persistent corporate buying pressure as evidence of the network’s increasing recognition among enterprise users, especially for payment and settlement solutions.

Technical data confirms this institutional accumulation. Support was firmly established at $0.39, where corporate trading volume reached 62.57 million tokens on October 5. Multiple resistance tests occurred at $0.41 before a decisive breakout fueled by heavy institutional buying. At 13:38, trading activity peaked with 2.86 million tokens exchanged, validating the breakout and setting the tone for continued upward momentum.

The ascending price trend from the $0.39 base suggests steady corporate accumulation, further reinforced by consistent higher closes during the final trading hours. Daily trading volumes well above the 24-hour average of 25.43 million tokens indicate a new phase of institutional interest in XLM.

Market strategists regard Stellar Lumens as one of the most undervalued payment-focused cryptocurrencies trading below $1.00. Many forecast potential gains toward the $1.00 level in the next wave of institutional adoption, driven by the expansion of blockchain-based payment systems across global finance.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Strategy reports $3.9B Bitcoin gain in Q3, becomes the 106th largest US public firm Gino Matos · 27 seconds ago · 2 min read

The company's holdings surpassed $80 billion in value for the first time as Bitcoin trades above $125,000.

Oct. 6, 2025 at 10:30 pm UTC

2 min read

Updated: Oct. 6, 2025 at 10:17 pm UTC

Cover art/illustration via CryptoSlate. Image includes combined content which may include AI-generated content.

Strategy reported $3.89 billion in unrealized gains on Bitcoin (BTC) during the third quarter of 2025, propelling the company to surpass Coinbase’s market cap.

The company’s holdings surpassed $80 billion in value for the first time as Bitcoin trades above $125,000. As of press time, bitcoin traded at $125,420.83, valuing the company’s digital asset portfolio at approximately $80.26 billion based on current market prices.

Strategy held $73.21 billion in Bitcoin carrying value on its balance sheet as of Sept. 30, with a related deferred tax liability of $7.43 billion. As a result, the current holdings are already over $7 billion larger less than one week after the tally.

As of Oct. 6, Strategy holds 640,031 BTC acquired at an aggregate purchase price of $47.35 billion with an average cost basis of $73,983 per BTC.

The company recorded an unrealized gain of $3.89 billion during the quarter ended Sept. 30, partially offset by a deferred tax expense of $1.12 billion.

Strategy adopted Accounting Standards Update No. 2023-08, effective Jan. 1, which requires the company to recognize increases or decreases in the fair value of digital assets in its consolidated statements of operations for each reporting period.

The company acquired 42,706 BTC during the third quarter at an aggregate purchase price of $4.95 billion with an average purchase price of $115,959 per BTC.

Strategy funded these purchases using net proceeds from multiple at-the-market equity offerings, including $2.07 billion from its class A common stock program, $2.47 billion from an underwritten offering of its STRC preferred stock, and smaller amounts from its STRF, STRK, and STRD preferred stock programs.

Strategy’s outstanding indebtedness totaled $8.24 billion as of Sept. 30, including $8.20 billion in convertible notes across six different series maturing between 2028 and 2032.

The company’s annual contractual interest expense on its convertible debt was $36.8 million, while its yearly dividends on preferred stock totaled $638.7 million.

Additionally, Strategy’s MSTR shares traded at $358.13 as of press time, making it the 105th largest publicly traded company in the US with a market capitalization surpassing $101 billion as of Oct. 6.

Coinbase ranks 108th among US public companies, with a market capitalization of over $99 billion.

Mentioned in this articleLatest Bitcoin Stories

Solana (SOL) has regained bullish momentum, rising 3.57% in a day and reclaiming strong technical footing amid growing institutional interest. The cryptocurrency is trading at $236.46, holding firmly above its ascending support structure — a pattern that has underpinned steady price recovery since mid-year. This structure signals sustained demand despite broader market volatility, setting the stage for a potential breakout.

Technical analysis shows key resistance around $238, a crucial barrier that, once cleared, could pave the way toward $251. Sustained movement beyond this level may validate a bullish continuation targeting $300, marking a possible 56% rebound. The Fibonacci retracement levels highlight potential consolidation zones, with the 0.618 level near $238 acting as a pivot point and the 0.786 level around $252 drawing attention from buyers. However, a dip below $227 could lead to a retest of lower support at $209, though the broader ascending trend remains intact.

Market optimism has been reinforced by Solana Company’s recent $530 million SOL purchase, one of the largest corporate acquisitions in the network’s history. This move underscores growing confidence among institutional investors in Solana’s long-term scalability and efficiency. By tightening circulating supply, such large-scale buys reduce selling pressure, strengthening SOL’s market position. Additionally, Grayscale’s Solana Trust (GSOL) now enables staking, potentially boosting institutional engagement once its regulatory approval as an ETP is finalized.

Overall, Solana’s technical resilience combined with robust institutional participation paints a bullish outlook. A decisive close above $251 could confirm an upward breakout, propelling the asset toward $300 and beyond. With increasing corporate adoption and fresh staking opportunities, Solana continues to solidify its position as one of the strongest performers in the crypto market.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Are Wall Street's rapid ETF approvals rewarding corporate tokens, and not grassroots decentralized networks?

Bitcoin broke its all-time high for the second time on Monday night, smashing past $127,000, as traders watched as the price of the OG crypto by market value hit $127,035 before climbing again to $127,253.

Opendoor's CEO just hinted that buying a house with bitcoin might not be far off. When asked whether the real estate tech firm would accept bitcoin and other digital assets for home purchases, CEO Kaz Nejatian didn't mince words: “We will. Just need to prioritize it.

Insider sales are common in public companies, but investors shouldn't ignore them, especially when unusually high. This may signal insiders view shares as overvalued, a bearish sign. Still, employees and large shareholders need to sell stock for cash. Investors must analyze each sale to understand its true message; not all are bearish.

Below, we’ll detail two of the market's most talked-about artificial intelligence (AI) stocks that have recently seen insider sales spike. Should investors truly worry about these sales, or are they simply distractions amid the big-time rallies in these stocks?

CRWV’s Hedge Fund Investor Massively Increased Sales in September
CoreWeave Today

$133.85 -0.94 (-0.70%)

As of 04:00 PM Eastern

52-Week Range$33.51▼

$187.00Price Target$127.64

First up is CoreWeave NASDAQ: CRWV, the NVIDIA NASDAQ: NVDA-backed neo cloud company that has seen its shares go on an incredible run. Since going public in March, shares are up by approximately 237%. The company has announced several deals with AI hyperscaler firms, leading to its huge gains. It also saw revenues rise by 207% last quarter and posted a backlog of $30.1 billion.

However, one of the company’s top investors is now moving out of the stock in a big way. Since Sept. 15, MarketBeat has tracked approximately $1.4 billion worth of insider selling from Magnetar Financial LLC, a hedge fund manager and one of the largest owners of CoreWeave shares. Magnetar's recent sales are notable for several reasons. First, all these sales are discretionary, not under a predetermined plan. They provide a much clearer bearish signal than planned sales.

Additionally, Magnetar’s CoreWeave sales in a span of less than three weeks amount to more than all the company’s insiders' sales in its history. That clearly amounts to a massive spike and should be a warning sign to investors. Lastly, Magnetar sold these shares at an average price of around $129. That’s around 4% below CoreWeave’s Oct. 2 closing price of nearly $135, further amplifying the bearish signal of Magnetar's sales. The firm was willing to sell billions in CoreWeave stock, even when it was trading lower than it currently is.

Broadcom's Insider Sales Soar, But How Much Trouble Do They Truly Spell?
Broadcom Today

$335.49 -2.88 (-0.85%)

As of 04:00 PM Eastern

52-Week Range$138.10▼

$374.23Dividend Yield0.70%

P/E Ratio85.58

Price Target$357.22

Semiconductor giant Broadcom NASDAQ: AVGO has also performed very impressively in 2025. Overall, shares have provided a total return of 47%, driven by robust demand for the firm’s custom AI chips. However, Broadcom has also seen insider sales balloon recently. In September alone, the company saw around $226 million worth of insider sales. That’s slightly more than the $222 million Broadcom saw from April to August, demonstrating the big uptick in selling. Given the stock’s huge appreciation, investors could view this as a red flag. However, it is also important to note that around $125 million, or 55% of these sales, were non-discretionary. This significantly mutes the bearish signal implied by the recent insider sales at Broadcom.

Broadcom’s discretionary sales in September average out to a price of around $340. With Broadcom shares trading at around $338, insiders may not see much more near-term upside in the stock. Despite insider sales, Broadcom remains a strongly growing, highly profitable, and technologically advanced company, maintaining solid long-term prospects. Chief Executive Officer Hock Tan’s long-term AI-driven compensation plan further supports this idea.

CRWV & AVGO: A Tale of 2 Different Insider Sale Signals
Based on the nature of their insider sales, those coming from CoreWeave insiders are much more worrisome than those from Broadcom insiders. Magentar’s sales aren’t overly surprising, given that CoreWeave shares have gone on an absolutely massive run. Overall, investors may want to consider whether smart money is noticing that CoreWeave shares are being driven too much by hype and not enough by fundamentals.  

Notably, the firm’s capital expenditures were $2.9 billion last quarter, around 2.4 times higher than its revenue of $1.2 billion. CoreWeave will eventually need to flip this dynamic over the next few years or risk the market changing its tune on this stock. Still, it is very possible that the market will keep rewarding this name for growth in the short term.

Should You Invest $1,000 in CoreWeave Right Now?Before you consider CoreWeave, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CoreWeave wasn't on the list.

While CoreWeave currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

HOUSTON--(BUSINESS WIRE)--Solaris Energy Infrastructure, Inc. (“Solaris”) (NYSE: SEI) today announced its intention to offer, subject to market and other conditions, $600,000,000 aggregate principal amount of convertible senior notes due 2031 (the “notes”) in a public offering registered under the Securities Act of 1933, as amended. Solaris also expects to grant the underwriters of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $90,000,000 principal amount of notes solely to cover over-allotments.

Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC and Santander US Capital Markets LLC are acting as the book-running managers for the offering.

The notes will be senior, unsecured obligations of Solaris, will accrue interest payable semi-annually in arrears and will mature on October 1, 2031, unless earlier repurchased, redeemed or converted. Noteholders will have the right to convert their notes in certain circumstances and during specified periods. Solaris will settle conversions by paying or delivering, as applicable, cash, shares of its Class A common stock, par value $0.01 per share (“Class A common stock”), or a combination of cash and shares of its Class A common stock, at Solaris’s election.

The notes will be redeemable, in whole or in part (subject to certain limitations), for cash at Solaris’s option at any time, and from time to time, on or after October 2, 2028 and on or before the 40th scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of Solaris’s Class A common stock exceeds 130% of the conversion price for a specified period of time. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

If certain corporate events that constitute a “fundamental change” occur, then, subject to a limited exception, noteholders may require Solaris to repurchase their notes for cash. The repurchase price will be equal to the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the applicable repurchase date.

The interest rate, initial conversion rate and other terms of the notes will be determined at the pricing of the offering.

Solaris intends to use the net proceeds from the offering to fund the cost of entering into the capped call transactions described below. Solaris expects to use the remainder of the net proceeds to purchase from Solaris Energy Infrastructure, LLC (“Solaris LLC”), its operating subsidiary, a subordinated convertible note to be issued by Solaris LLC with substantially similar economic terms as the notes (also taking into account the effect of the capped call transactions), and Solaris LLC expects to use such net proceeds to (i) repay the outstanding principal amount of $320.9 million (plus accrued and unpaid interest and any make-whole or other prepayment premium) under and terminate the Term Loan Agreement and (ii) fund growth capital for additional power generation equipment, including new natural gas turbines and complementary “balance of plant” electrical equipment, to support customer activity (which Solaris expects will include the funding of a turbine expansion opportunity to purchase approximately 80 MW of new turbine capacity to be delivered late in the fourth quarter of 2025).

If the underwriters exercise their option to purchase additional notes, then Solaris intends to use a portion of the additional net proceeds to fund the cost of entering into additional capped call transactions as described below and will transfer the remainder to Solaris LLC in exchange for an increase to the note it previously issued to Solaris.

In connection with the pricing of the notes, Solaris expects to enter into privately negotiated capped call transactions with one or more of the initial purchasers or their affiliates and/or other financial institutions (the “option counterparties”). The capped call transactions are expected to cover, subject to anti-dilution adjustments substantially similar to those applicable to the notes, the number of shares of Solaris’s Class A common stock that will initially underlie the notes.

The capped call transactions are expected generally to reduce the potential dilution to Solaris’s Class A common stock upon any conversion of the notes and/or offset any potential cash payments Solaris is required to make in excess of the principal amount of converted notes, as the case may be, upon any conversion of the notes, with such reduction and/or offset subject to a cap. If, however, the market price per share of Solaris’s Class A common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the capped call transactions. If the underwriters exercise their option to purchase additional notes, then Solaris expects to enter into additional capped call transactions with the option counterparties.

In connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into cash-settled over-the-counter derivative transactions with respect to Solaris’s Class A common stock concurrently with, or shortly after, the pricing of the notes, including with certain investors in the notes, and may unwind these derivative transactions and purchase shares of Solaris’s Class A common stock following the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Solaris’s Class A common stock or the notes at that time.

In addition, the option counterparties and/or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Solaris’s Class A common stock and/or purchasing or selling Solaris’s Class A common stock or other securities of Solaris in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so (x) following any conversion of the notes, any repurchase of the notes by Solaris on any fundamental change repurchase date or any redemption date, (y) following any other repurchase of the notes if Solaris elects to unwind a corresponding portion of the capped call transactions in connection with such repurchase and (z) if Solaris elects otherwise to unwind all or a portion of the capped call transactions). This activity could also cause or avoid an increase or decrease in the market price of Solaris’s Class A common stock or the notes, which could affect the ability of noteholders to convert the notes, and, to the extent the activity occurs during any observation period related to a conversion of notes, it could affect the number of shares and value of the consideration that noteholders will receive upon conversion of the notes.

In a separate press release, Solaris also announced that Morgan Stanley & Co. LLC, acting on behalf of itself and/or its affiliates (in such capacity, the “delta offering underwriter”), intends to offer, in a separate, underwritten offering, a number of shares of Solaris’s Class A common stock borrowed from third parties (the “concurrent delta offering”), to facilitate hedging transactions (whether physical and/or through derivatives) by some of the purchasers of the notes. The number of shares of Solaris’s Class A common stock subject to the concurrent delta offering will be determined at the time of pricing of the concurrent delta offering and is expected to be no greater than commercially reasonable initial short positions of such hedging investors in the notes. The completion of the offering of notes is contingent on the completion of the concurrent delta offering, and the completion of the concurrent delta offering is contingent on the completion of the offering of notes. This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any Class A common stock in the concurrent delta offering.

The offering of notes is being made pursuant to an effective shelf registration statement on file with the Securities and Exchange Commission (the “SEC”). The offering will be made only by means of a prospectus supplement and an accompanying prospectus. An electronic copy of the preliminary prospectus supplement, together with the accompanying prospectus, is available on the SEC’s website at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement, together with the accompanying prospectus, can be obtained by contacting: Morgan Stanley, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department, Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282, Attention: Prospectus Department, by email at [email protected] or by telephone at 866-471-2526 and Santander US Capital Markets LLC, 437 Madison Avenue, New York, NY 10022, Attention: ECM Syndicate, by email at [email protected] or by telephone at 833-818-1602.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities referred to in this press release, nor will there be any sale of any such securities, in any state or other jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Solaris

Solaris Energy Infrastructure, Inc. (NYSE:SEI) provides scalable equipment-based solutions for use in distributed power generation as well as the management of raw materials used in the completion of oil and natural gas wells. Headquartered in Houston, Texas, Solaris serves multiple U.S. end markets, including energy, data centers, and other commercial and industrial sectors.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, but are not limited to, statements regarding the anticipated terms of the notes being offered, the completion, timing and size of the proposed offerings, the intended use of the proceeds and the other risks discussed in Part I, Item 1A. “Risk Factors” in Solaris’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 5, 2025, the risks discussed in Part II, Item 1A. “Risk Factors” in Solaris’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025 filed with the SEC on May 7, 2025 and the risks discussed in Part II, Item 1A. “Risk Factors” in Solaris’s Quarterly Report on Form 10-Q for the three months ended June 30, 2025 filed with the SEC on August 1, 2025. Forward-looking statements are based on Solaris’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, Solaris’s actual results may differ materially from those contemplated by the forward-looking statements. Factors that could cause Solaris’s actual results to differ materially from the results contemplated by such forward-looking statements include, but are not limited to, the factors discussed or referenced in Solaris’s filings made from time to time with the SEC. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Factors or events that could cause Solaris’s actual results to differ may emerge from time to time, and it is not possible for Solaris to predict all of them. Solaris undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

More News From Solaris Energy Infrastructure, Inc.

The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little REFILE - CORRECTING LOCATION Purchase Licensing Rights, opens new tab

SummaryCompaniesCourt upholds Medicare's drug price negotiation powerNovo Nordisk's constitutional challenges rejected by 3rd CircuitMultiple drugmakers' lawsuits against Medicare program have failed in appellate courtsCHICAGO, Oct 6 (Reuters) - A federal appeals court on Monday rejected Novo Nordisk's

(NOVOb.CO), opens new tab challenge to the U.S. government’s program that gives its Medicare health insurance plan the power to negotiate lower drug prices, the latest in a barrage of lawsuits brought by drugmakers to fail.

The Philadelphia-based 3rd U.S. Circuit Court of Appeals affirmed a lower court’s ruling dismissing the Danish drugmaker’s challenge to the program and the Centers for Medicare and Medicaid Services' selection of six of its insulin products for price negotiations.

Sign up here.

A unanimous three-judge panel rejected Novo’s constitutional challenges to the program, which was part of Democratic former President Joe Biden’s Inflation Reduction Act, and said the law specifically bars courts from reviewing the drugs selected.

A Novo Nordisk spokesperson said the company was assessing its options to appeal the ruling.

A spokesperson for the White House did not immediately respond to a request for comment.

President Donald Trump has put pressure on drugmakers to lower their prices in recent months, as Americans pay more for pharmaceuticals than any other nation.

The Inflation Reduction Act requires pharmaceutical companies to negotiate drug prices with Medicare, which covers 66 million people. The negotiations got under way despite the drugmakers' lawsuits, with the initial round of drug prices set to take effect next year.

Novo is among several pharmaceutical companies to challenge the program, claiming it violated its constitutional rights to due process and free speech. Nearly all have failed.

In May, the 3rd Circuit upheld a lower court’s ruling dismissing AstraZeneca's

(AZN.L), opens new tab challenge, saying the company had no protected constitutional right to sell its drugs to the government at a price higher than what it wants to pay. In September, the court ruled similarly in challenges brought by Bristol Myers Squibb

(BMY.N), opens new tab and Novartis

(NOVN.S), opens new tab, court records show.

Monday’s ruling, authored by Circuit Judge Thomas Hardiman, an appointee of Republican President George W. Bush, pointed to the court’s earlier precedents to reject Novo’s constitutional challenges.

Hardiman was joined on the panel by Circuit judges Peter Phipps, who was appointed by Trump, and Arianna Freeman, a Biden appointee.

The case is Novo Nordisk v. HHS et al, case number 24-2510 in the 3rd U.S. Circuit Court of Appeals.

For Novo Nordisk: Ashley Parrish of King & Spalding

For HHS: Lindsey Powell of the U.S. Department of Justice

Reporting by Diana Novak Jones in Chicago; Editing by Matthew Lewis

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Diana reports on product liability, litigation, mass torts and the plaintiffs' bar. She previously worked at Law360 and the Chicago Sun-Times.

HOUSTON--(BUSINESS WIRE)--Solaris Energy Infrastructure, Inc. (“Solaris”) (NYSE:SEI) announced today, in a separate press release, its intention to offer, in an underwritten public offering, subject to market and other conditions, $600,000,000 aggregate principal amount of convertible senior notes due 2031 (the “notes”), plus up to an additional $90,000,000 aggregate principal amount of notes that the underwriters of the notes offering have the option to purchase from Solaris.

Concurrently with the offering of the notes, Morgan Stanley & Co. LLC, acting on behalf of itself and/or its affiliates (in such capacity, the “delta offering underwriter”), intends to offer, in a separate, underwritten offering, a number of shares of Solaris’s Class A common stock, par value $0.01 per share (“Class A common stock”), borrowed from third parties (the “concurrent delta offering”), to facilitate hedging transactions (whether physical and/or through derivatives) by some of the purchasers of the notes. The number of shares of Class A common stock subject to the concurrent delta offering will be determined at the time of pricing of the concurrent delta offering and is expected to be no greater than commercially reasonable initial short positions of such hedging investors in the notes. No new shares of Class A common stock will be issued, and Solaris will not receive any proceeds from the concurrent delta offering. The concurrent delta offering and the offering of the notes are contingent upon one another.

Solaris has filed a shelf registration statement on Form S-3 (including a prospectus) with the Securities and Exchange Commission (the “SEC”). The concurrent delta offering is being made only by means of the prospectus supplement and the accompanying prospectus. Before you invest, you should read the prospectus supplement and the accompanying prospectus and other documents that Solaris has filed with the SEC for more complete information about Solaris and the offering. You may obtain these documents free of charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a copy of the prospectus supplement and the accompanying prospectus may be obtained from Morgan Stanley, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department.

About Solaris

Solaris Energy Infrastructure, Inc. (NYSE:SEI) provides scalable equipment-based solutions for use in distributed power generation as well as the management of raw materials used in the completion of oil and natural gas wells. Headquartered in Houston, Texas, Solaris serves multiple U.S. end markets, including energy, data centers, and other commercial and industrial sectors.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, but are not limited to, the completion, timing and size of the proposed offering referred to herein, the completion, timing and size of the concurrent offering of the notes and the other risks discussed in Part I, Item 1A. “Risk Factors” in Solaris’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 5, 2025, the risks discussed in Part II, Item 1A. “Risk Factors” in Solaris’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025 filed with the SEC on May 7, 2025 and the risks discussed in Part II, Item 1A. “Risk Factors” in Solaris’s Quarterly Report on Form 10-Q for the three months ended June 30, 2025 filed with the SEC on August 1, 2025. Forward-looking statements are based on Solaris’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, Solaris’s actual results may differ materially from those contemplated by the forward-looking statements. Factors that could cause Solaris’s actual results to differ materially from the results contemplated by such forward-looking statements include, but are not limited to, the factors discussed or referenced in Solaris’s filings made from time to time with the SEC. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Factors or events that could cause Solaris’s actual results to differ may emerge from time to time, and it is not possible for Solaris to predict all of them. Solaris undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

More News From Solaris Energy Infrastructure, Inc.

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in KinderCare Learning Companies, Inc. ("KinderCare Learning Companies, Inc." or the "Company") (NYSE: KLC) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KinderCare Learning Companies, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of KinderCare common stock in or traceable to the Company’s October 2024 initial public offering Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/kindercare-learning-companies-inc-lawsuit-submission-form?prid=170637&wire=3

KLC investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) numerous incidents of child abuse, neglect, and harm had occurred at KinderCare facilities; (b) KinderCare did not provide the “highest quality care possible” at its facilities, and, indeed, in numerous instances had failed to provide even basic care, meet minimum standards in the child care industry, or comply with the laws and regulations governing the care of children; and (c) as a result of (a)-(b) above, KinderCare was exposed to a material, undisclosed risk of lawsuits, adverse regulatory action, negative publicity, reputational damage, and business loss.

WHAT'S NEXT? If you suffered a loss in KinderCare Learning Companies, Inc. during the relevant time frame, you have until October 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cytokinetics investors who were adversely affected by alleged securities fraud between December 27, 2023 and May 6, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=170638&wire=3

CYTK investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the complaint, defendants made materially false and misleading statements regarding the timeline for the New Drug Application (“NDA”) submission and approval process for aficamten. Specifically, defendants represented that the Company expected approval from the U.S. Food and Drug Administration (“FDA”) for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 PDUFA date, and failed to disclose material risks related to the Company’s failure to submit a Risk Evaluation and Mitigation Strategy (“REMS”) that could delay the regulatory process. On May 6, 2025, during an earnings call, it was revealed that the Company had multiple pre-NDA meetings with the FDA discussing safety monitoring and risk mitigation but chose to submit the NDA without a REMS, relying on labeling and voluntary education materials. This confirmed defendants’ awareness of potential REMS requirements and their reckless decision to omit it from the initial submission, misleading investors about the regulatory timeline. As a result of defendants’ false and misleading statements, class members purchased Cytokinetics’ common stock at artificially inflated prices and suffered significant losses when the truth was revealed.

WHAT'S NEXT? If you suffered a loss in Cytokinetics during the relevant time frame, you have until November 17, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

October 06, 2025 16:49 ET

 | Source:

CPS Technologies Corp.

NORTON, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- CPS Technologies Corp. (NASDAQ: CPSH) (“CPS” or the “Company”), today announced that it intends to offer shares of its common stock in an underwritten public offering. CPS also expects to grant to the underwriters of the offering a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the underwritten public offering on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Roth Capital Partners is acting as the sole book-running manager for the offering.

A shelf registration statement on Form S-3 (File No. 333-282266) relating to the shares of common stock to be issued in the proposed offering was originally filed with the Securities and Exchange Commission (the “SEC”) on September 20, 2024, and declared effective by the SEC on October 17, 2024.

A preliminary prospectus supplement and accompanying prospectus related to the offering will be filed with the SEC. Copies of the preliminary prospectus supplement and accompanying prospectus relating to the offering, when available, may be obtained from Roth Capital Partners, LLC, 888 San Clemente, Suite 400, Newport Beach, CA 92660, (800) 678-9147 or by accessing the SEC’s website, www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About CPS Technologies Corp.

CPS is a technology and manufacturing leader specializing in delivering high-performance material solutions for its customers. The company’s products and intellectual property address critical needs in a variety of applications, including electric trains and subway cars, wind turbines, hybrid vehicles, electric vehicles, Navy ships, the smart electric grid, 5G infrastructure and others. CPS hermetic packages can be found in many Aerospace and Satellite applications. CPS’ armor products provide exceptional ballistic protection and environmental durability at very light weight. CPS is committed to innovation and to supporting our customers in building solutions for the transition to clean energy. The Company articulates its Vision as follows: “To pioneer the next generation of high-performance materials and solve the world’s toughest engineering challenges.”

Safe Harbor

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the proposed public offering, including the completion of the proposed public offering on the anticipated terms, if at all, and other statements that are not historical facts. These forward-looking statements are identified by the use of terms and phrases such as “will,” “intends,” “believes,” “expects,” “plans,” “anticipates” and similar expressions. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including market conditions, risks associated with the cash requirements of the Company’s business and other risks detailed from time to time in the Company’s filings with the SEC, including its Annual Report on Form 10-K and other periodic reports filed with the SEC, and represent our views only as of the date they are made and should not be relied upon as representing our views as of any subsequent date. Forward-looking statements contained in this press release speak only as of the date of this release. Subsequent events or circumstances occurring after such date may render these statements incomplete or out of date. The Company expressly disclaims any obligation to update any forward-looking statements or information in this release.

CPS Technologies Corporation
111 South Worcester Street
Norton, MA 02766
www.cpstechnologysolutions.com

Investor Relations:
Chris Witty
646-438-9385
[email protected]

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in KBR, Inc. ("KBR, Inc." or the "Company") (NYSE: KBR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KBR, Inc. investors who were adversely affected by alleged securities fraud between May 6, 2025 and June 19, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=170641&wire=3

KBR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) despite the knowledge that the U.S. Department of Defense’s Transportation Command, for months, had material concerns with HomeSafe’s ability to fulfill the global household goods contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants’ statements about KBR’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT'S NEXT? If you suffered a loss in KBR, Inc. during the relevant time frame, you have until November 18, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=170643&wire=3

UNCY investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Unicycive’s readiness and ability to satisfy the FDA’s manufacturing compliance requirements was overstated; (ii) the oxylanthanum carbonate new drug application’s regulatory prospects were likewise overstated; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Unicycive Therapeutics, Inc. during the relevant time frame, you have until October 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fluor Corporation ("Fluor Corporation" or the "Company") (NYSE: FLR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fluor Corporation investors who were adversely affected by alleged securities fraud between February 18, 2025 and July 31, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=170645&wire=3

FLR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) costs associated with the Company’s infrastructure projects; Gordie Howe, I-635/LBJ, and I-35 were growing because of, inter alia, subcontractor design errors, price increases, and scheduling delays; (ii) the foregoing, as well as customer reduction in capital spending and client hesitation around economic uncertainty, was having, or was likely to have, a significant negative impact on the Company’s business and financial results; (iii) accordingly, Fluor’s financial guidance for FY 2025 was unreliable and/or unrealistic, the effectiveness of the Company’s risk mitigation strategy was overstated, and the impact of economic uncertainty on the Company’s business and financial results was understated; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Fluor Corporation during the relevant time frame, you have until November 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Dow Inc. ("Dow Inc." or the "Company") (NYSE: DOW) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dow Inc. investors who were adversely affected by alleged securities fraud between January 30, 2025 and July 23, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=170644&wire=3

DOW investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Dow’s ability to mitigate macroeconomic and tariff-related headwinds, as well as to maintain the financial flexibility needed to support its lucrative dividend, was overstated; (ii) the true scope and severity of the foregoing headwinds’ negative impacts on Dow’s business and financial condition was understated, particularly with respect to competitive and pricing pressures, softening global sales and demand for the Company’s products, and an oversupply of products in the Company’s global markets; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Dow Inc. during the relevant time frame, you have until October 28, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortinet, Inc. ("Fortinet, Inc." or the "Company") (NASDAQ: FTNT) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortinet, Inc. investors who were adversely affected by alleged securities fraud between November 8, 2024 and August 6, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=170648&wire=3

FTNT investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed that defendants knew that the refresh cycle would never be as lucrative as they represented, nor could it, because it consisted of old products that were a “small percentage” of the Company’s business. Moreover, defendants misrepresented and concealed that they did not have a clear picture of the true number of FortiGate firewalls that could be upgraded. And while telling investors that the refresh would gain momentum over the course of two years, Fortinet misrepresented and concealed that it had aggressively pushed through roughly half of the refresh in a period of months, by the end of 2Q 2025.

WHAT'S NEXT? If you suffered a loss in Fortinet, Inc. during the relevant time frame, you have until November 21, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- A new class-action lawsuit is targeting KBR, Inc. (NYSE: KBR), alleging the company made misleading statements to investors in the weeks leading up to the abrupt cancellation of a major military contract. The suit, Norrman v. KBR, Inc., et al., No. 4:25-cv-04464 (S.D. Tex.), was filed after the company’s stock plunged following the termination of a multi-billion-dollar deal.

National shareholders rights firm Hagens Berman urges KBR investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Class Period: May 6, 2025 – June 19, 2025
Lead Plaintiff Deadline: Nov. 18, 2025
Visit: www.hbsslaw.com/investor-fraud/kbr
Contact the Firm Now: [email protected]
                                        844-916-0895

KBR, Inc. (KBR) Securities Class Action:

The legal action seeks to represent shareholders who purchased KBR securities between May 6, 2025, and June 19, 2025. It claims that KBR executives provided a falsely optimistic outlook on a crucial partnership just as it was on the verge of collapse.

The litigation stems from the Department of Defense U.S. Transportation Command (TRANSCOM) canceling its global household goods contract with HomeSafe Alliance LLC, a joint venture led by KBR. The decision, announced on June 20, 2025, caused KBR shares to fall over 7% as investors reacted to the loss of a contract valued at up to $20 billion over a potential nine-year term.

The suit highlights a key discrepancy: on May 6, 2025, during its Q1 earnings call, KBR assured investors that the HomeSafe partnership was "strong" and "excellent" and that the company was "very confident in the future of this program."

However, just weeks later, on June 19, 2025, HomeSafe disclosed that TRANSCOM had terminated the contract for cause. The termination reportedly came after months of operational issues, including chronic delays, missed pickups, and a rise in complaints about damaged goods. The complaint alleges that KBR was aware of TRANSCOM’s material concerns but chose to conceal them from investors. The lawsuit argues that this misrepresentation led to the significant financial losses suffered by shareholders.

“We’re focused on whether KBR may have intentionally misled investors about the true status of the relationship with TRANSCOM and the contract,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in KBR and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the KBR case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding KBR should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895